{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:03:33Z","timestamp":1789409013893,"version":"build-2803163510"},"reference-count":106,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/13543776.2020.1751817","type":"journal-article","created":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T14:05:11Z","timestamp":1586095511000},"page":"467-480","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Antiviral therapeutics for chikungunya virus"],"prefix":"10.1080","volume":"30","author":[{"given":"Ritu","family":"Ghildiyal","sequence":"first","affiliation":[{"name":"Center for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, U P, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Gabrani","sequence":"additional","affiliation":[{"name":"Center for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Noida, U P, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30385-1"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760170044"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/82_2019_158"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2018.1478777"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2018.1559708"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-016-1505-6"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005724"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.3390\/v6114628"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03184-15"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007239"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/tmr.8146","volume":"3","author":"Stelitano D","year":"2019","journal-title":"Transl Med Rep"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.3390\/v11030294"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00077"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20177862"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.3390\/v10050235"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12461.1"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3390\/v10060294"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1033"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.06.049"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.64.01.63"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126360"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku209"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.04.002"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21663"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.3390\/v10050268"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.03.182"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126881"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2003.09.005"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133511"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1038\/srep31819"},{"key":"CIT0033","author":"Haese N","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s13337-019-00547-0"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.01.037"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EI10-0017-2016"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b02900"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.11.001"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.157"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.3390\/v10110592"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01382-16"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2014.05.015"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22030505"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.7b00233"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.07.009"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA16640G"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2018.1509732"},{"key":"CIT0049","first-page":"1","author":"Khan N","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12301.1"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1629413"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11320"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.6026\/97320630015439"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.08.015"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.06.017"},{"issue":"2","key":"CIT0056","doi-asserted-by":"crossref","first-page":"e01389","DOI":"10.1128\/AAC.01389-18","volume":"63","author":"Ferreira AC","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1595591"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13242.1"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8030128"},{"key":"CIT0060","unstructured":"Emory University. Nucleotide and nucleoside therapeutic compositions and uses related thereto. US10149859; 2018."},{"key":"CIT0061","unstructured":"Aravive Biologics, Inc. Antiviral activity of Gas6 inhibitor. US10137173; 2018"},{"key":"CIT0062","unstructured":"Alleron Therapeutics, Inc. Peptidomimetic macrocycles. US10022422; 2018."},{"key":"CIT0064","unstructured":"F. Hoffmann-La Roche AG. Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease. US9988390; 2018."},{"key":"CIT0065","unstructured":"Kineta, Inc. Anti-viral compounds. pharmaceutical compositions, and methods of use thereof. US9884876; 2018."},{"key":"CIT0066","unstructured":"The Trustees of Princeton University. Treatment of viral infections by modulation of host cell metabolic pathways. US9757407; 2017."},{"key":"CIT0069","unstructured":"Chung yuan christian university, national defensive medical center. Method for treating Chikungunya Virus Infection. US9381175. 2016."},{"key":"CIT0070","unstructured":"Pop Test Oncology LLC. Pharmaceutical compositions and methods. US10238666; 2019."},{"key":"CIT0072","unstructured":"Stamets, Edward P. Antiviral activity from medicinal mushrooms and their active constituents. US9931316; 2018."},{"key":"CIT0073","unstructured":"Griffith University. Treatment of alphavirus-induced inflammation. US20190255097; 2019"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601426"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005637"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01780-12"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.07.018"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008061"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-019-00135-y"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208851"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003139"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis674"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003312"},{"key":"CIT0084","unstructured":"International business machines corporation; agency for science, technology and research; national university of Singapore. Cationic polyamines for treatment of viruses. US 9682100; 2017."},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01032-14"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav5062"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw6647"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1111\/pbi.13194"},{"key":"CIT0089","unstructured":"Agency for Science Technology Research. Binding molecules against Chikungunya virus and uses thereof. US9738704; 2017."},{"key":"CIT0090","unstructured":"Institute Pasteur. Anti-chikungunya monoclonal antibodies and uses thereof. US8449887; 2013"},{"key":"CIT0092","unstructured":"Agenus INC.; Ludwig institute for cancer research ltd; Memorial sloan kettering cancer center. Anti-CTLA-4 antibodies and methods of use thereof. US10144779; 2018."},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.08.004"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7010002"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S181574"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61185-5"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32488-7"},{"issue":"4","key":"CIT0098","doi-asserted-by":"crossref","first-page":"e01274","DOI":"10.1128\/JVI.01274-17","volume":"92","author":"Erasmus JH","year":"2018","journal-title":"J Virol"},{"key":"CIT0099","unstructured":"Modernatx Inc. Chikungunya virus RNA vaccines. US20190008947; 2019."},{"key":"CIT0100","unstructured":"United States, As represented by the secretary of the army, fort detrick. inactived vaccine for chikungunya virus. US20190054161; 2019."},{"key":"CIT0101","unstructured":"Medigen, INC., Frederick. Infectious DNA Vaccines Against Chikungunya Virus. US9694065; 2017."},{"key":"CIT0102","unstructured":"Institute Pasteur; Themis bioscience GMBH; Centre National; De La recherche scientifioue. recombinant measles virus expressing chikungunya virus polypeptides and their applications. US9655961; 2017."},{"key":"CIT0103","unstructured":"The United States of America, as represented by the secretary, department of health and human services. Virus-Like Particles (Vlps) Prepared From Chikungunya Virus Structural Proteins. US9353353; 2016."},{"key":"CIT0104","unstructured":"Bharat Biotech International Limited. Vaccine for Chikungunya virus Infection. US8865184; 2014."},{"key":"CIT0105","unstructured":"The Board of Regents of the University of Texas System. Chimeric Chikungunya virus and uses thereof. US8343506; 2013."},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2016-0010"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.4103\/0972-124X.118309"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100941"},{"key":"CIT0110","first-page":"2014:631642","author":"Parashar D","year":"2014","journal-title":"BioMed Res Int"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002405"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046396"},{"key":"CIT0113","unstructured":"Indian Council of Medical Research. RNAi agent for inhibition of chikungunya virus. US9574195; 2017."},{"key":"CIT0114","unstructured":"Nanosur LLC. Post-transcriptionally chemically modified double strand RNAs. US10131911; 2018."},{"key":"CIT0115","unstructured":"Biomics Biotechnologies Co Ltd. Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas. US9284560; 2012."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2020.1751817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T13:07:35Z","timestamp":1666271255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2020.1751817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/13543776.2020.1751817"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2020.1751817","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}